What happened
In an October 7, 2026, update on a multistate Salmonella Bovismorbificans outbreak, FDA said its investigation had traced implicated broccoli sprouts and microgreens to a contaminated seed lot. A sample of the suspected seeds tested positive, and whole-genome sequencing matched the Salmonella strain in that sample to the strain found in people who became ill.
Eden Brothers recalled identified calabrese broccoli seed lots on October 7. FDA also lists a Home Grown seed product recalled earlier. Its instruction concerns the specified recalled seeds: do not eat, serve, or sell them.
Why it matters
Investigators had implicated broccoli sprouts and microgreens; identifying the seed supply changes where prevention efforts can focus. Seeds may already have been distributed before sprouts are grown, so a recall of specified seed lots can reach purchasers and sellers beyond a single finished sprout product.
For those handling the listed products, FDA’s direction is immediate and concrete: the recalled seeds should not be eaten, served, or sold. For everyone else, the distinction is just as important. The laboratory finding strengthens attribution to the implicated supply; it is not a blanket finding that all broccoli seeds are contaminated.
Evidence
FDA identifies Eden Brothers lots 1022067 and 1022068, associated with supplier lot W4105, and a specified Home Grown package marked AUG172026. The recalled Eden Brothers seeds had been sold nationwide through its website and Amazon. The product names and lot markings matter because FDA’s do-not-use direction is specific to recalled products, not to broccoli seeds generally.
Sequencing found that Salmonella from an implicated seed sample matched the outbreak strain found in patients. That gives investigators laboratory evidence connecting the suspected seed supply to the outbreak, rather than relying only on accounts of foods eaten. The reviewed FDA update does not establish a current case or hospitalization count for this story, so no such total can be inferred from it.
What remains unknown
FDA says the investigation is continuing. It remains unclear whether further customers, products, or illnesses will be linked to the implicated lot. The genomic match supports the identified source, but it does not establish that every broccoli-seed product is affected or settle the full extent of the outbreak. A separate alfalfa-sprout investigation should not be merged with this one.
Who may be affected
U.S. purchasers of the specified seeds, people growing sprouts from them, retailers and food-service operators handling them, and people vulnerable to severe foodborne illness.
AXIONOVA connection
This is a case in which genomic laboratory evidence helps investigators identify a source beyond the finished sprouts or microgreens. The relevant follow-up is whether FDA or CDC identifies further implicated lots or changes the investigation. A match to a recalled seed supply should not be broadened into a claim about all broccoli seeds.
What ALETHA can explain
ALETHA can explain how matching bacterial genomes helps trace an outbreak and why an instruction for specified recalled lots does not apply automatically to an entire category of food.
Action posture
Urgent official safety direction: FDA explicitly directs the public and sellers not to use the specified recalled lots.